Skin Cancer Vaccine

Science & Medicine

Thursday, August 20, 2026 - 7 minutes

A new personalized vaccine, called Intismeran, was given in combination with Keytruda, an immunotherapy drug already used in cancer treatment, stopped skin cancer returning in patients during a trial, representing a potentially watershed moment in cancer treatment. The vaccine, developed by drug companies Merck & Co and Moderna, was given to patients with high-risk melanoma, a type of skin cancer, after they had surgery. The two companies are testing other similar personalized vaccines for lung, bladder, and kidney cancers.

Subscribe to this podcast

Share

Listen Live
Now Playing

Laguna Beach Vibe

Latest Podcasts

  • The Mayor

    Mayor Mark Orgill 8-27-2026

    Weekly discussion with Laguna Beach Mayor, Mark Orgill

  • Science & Medicine

    Daily Pill for Pancreatic Cancer

    Ed talks about the breakthrough drug for pancreatic cancer

  • Ed's Personal Stash

    The Music of Dolly Parton

    Ed dedicates this personal stash to Dolly Parton songs and collaborations

  • Ed's Personal Stash

    R.I.P. Dolly Parton

    Ed pays tribute to the iconic Dolly Parton

  • News & Observations

    Lisa's Journey

    Lisa fills us in on what she's been up to this summer.

Search